Michael is a senior finance director at Thermo Fisher Scientific, leading global finance for their $1B Large Molecule portfolio. With a background in both biochemistry and economics, he has extensive experience in P&L ownership, M&A, and corporate FP&A in the Life Science sector. Colleagues have described him as a "keen learner" and "detail oriented. "
His academic journey includes an MBA from Boston College and undergraduate degrees from Wesleyan University, where he received awards for excellence in biochemistry. This scientific foundation complements his deep expertise in finance, giving him a unique perspective in the biotech industry.
Unique fact: Michael co-authored a scientific paper on protein dynamics published in *The Journal of Physical Chemistry B* during his undergraduate studies.
Read the full overview →They are unlikely to ever become strong champions even when the conversations are going well; you should focus on cultivating other champions They typically tend to be late adopters even when they seem friendly and excited about what you have to sell They are often friendly and nice, but can sometimes suprise you with their piercing questions
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.